Skip to content
  • ABOUT US
  • CONTACT
top-right
X page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
Tumori Journal
Tumori JournalTumori Journal
  • Home
  • Podcast
  • Articles
  • Publish with us
  • Home
  • Podcast
  • Articles
  • Publish with us

Daily Archives: September 29, 2026

You are here:
  1. Home
  2. 2026
  3. September
  4. 29

Growth in oncology clinical trials and decline of independent research: Insights from the 22nd AIFA National Report on clinical trials

EditorialBy Margherita ZanvitSeptember 29, 2026

The 22nd National Report on Clinical Trials of Medicinal Products published by the Italian Medicines Agency (AIFA) in July 2026 highlights contrasting trends in Italian clinical research.

Quality of life in first-line trials for endometrial cancer: A systematic review

Review ArticleBy Margherita ZanvitSeptember 29, 2026

As treatment strategies evolve in advanced or metastatic endometrial cancer (EC), quality of life (QoL) has become a key parameter in evaluating therapeutic value. This systematic review summarizes QoL outcomes from pivotal trials that have shaped clinical practice in advanced EC.

Comparison of infusion-related reactions to chemotherapy versus targeted therapy: A four-year experience at the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori Milano

Research ArticleBy Margherita ZanvitSeptember 29, 2026

Infusion reactions (IRs) are a significant concern in oncology due to unpredictable onset and a lack of standardized management guidelines.

Tumori Journal
2026 ©Tumori Journal
  • Privacy Policy
  • Cookie Policy
Footer
Go to Top